Broyhill
Our archive holds 6 letters from Broyhill, behind 12 investment theses and positions in 26 companies. Every quote below is copied verbatim from the letter it came from.
Get an email when this fund publishes its next letter
4 strategies
Broyhill publishes a letter per strategy. Each one has its own page with what it holds, what it bought and what it wrote.
- Broyhill AM2
15 companies
- Broyhill Equity Highlights2
9 companies
- Broyhill Asset Management1
7 companies
- Broyhill Equity Composite1
11 companies
YTD +1.9% (Sep 30, 2026)
Returns as reported in each strategy’s latest letter, extracted automatically and not verified by us; one share class, in its own currency. Not investment advice. Past performance does not predict future returns.
What they bought and sold · 23 moves
- ExitedCACI International Inc.September 2026
“Finally, we sold CACI in September after the shares rallied on its fiscal fourth-quarter report.”
Read the letter - September 2026
“We exited the parent, now a pure-play automation company, when that discount to its peers closed.”
Read the letter - AddedValvoline Inc.September 2026
“We added to the position in September.”
Read the letter - September 2026
“Microsoft added about 110 basis points, most of it in July, the month we added to the position.”
Read the letter - ExitedMidera Food ProcessingSeptember 2026
“We sold Midera Food Processing following its spin out from Middleby.”
Read the letter - ExitedRentokil Initial plcSeptember 2026
“We trimmed the position in September and exited the position after quarter-end.”
Read the letter - TrimmedIQVIA Holdings Inc.September 2026
“We trimmed the position in August as part of our portfolio construction discipline.”
Read the letter - New positionAlphabet Inc.September 2026
“We initiated one position during the quarter in Alphabet”
Read the letter - ExitedSotera HealthMay 2026
“The sponsors completed a 31.8 million-share secondary in May, fully exiting their Sotera Health positions and terminating the stockholders' agreement that had given them board control.”
Read the letter - AddedIQVIAMarch 2026
“In the wake of this latest leg down, we significantly increased our investments in the sectors, bringing both IQVIA and Sotera Health into our top holdings.”
Read the letter - ExitedFresenius Medical CareMarch 2026
“In addition to Ball, noted previously, we liquidated profitable investments in Kenedy Wilson and Fresenius Medical Care,”
Read the letter - New positionSmurfit WestRockMarch 2026
“We initiated a new position in Smurfit WestRock with proceeds from Ball,”
Read the letter - ExitedEvolutionMarch 2026
“We also fully liquidated two positions – Evolution and Avantor - after reducing exposure to each, to reinvest in higher conviction ideas.”
Read the letter - New positionFloor and DécorMarch 2026
“And we established two new positions in the depressed housing industry – Masco and Floor and Décor,”
Read the letter - TrimmedPhillip MorrisMarch 2026
“During the quarter, we booked a portion of our gains on Phillip Morris and fully liquidated several positions.”
Read the letter - New positionMascoMarch 2026
“And we established two new positions in the depressed housing industry – Masco and Floor and Décor,”
Read the letter - AddedSotera HealthMarch 2026
“we significantly increased our investments in the sectors, bringing both IQVIA and Sotera Health into our top holdings.”
Read the letter - New positionMicrosoftMarch 2026
“We bought Microsoft as the stock’s valuation declined to levels in line with the broader market.”
Read the letter - TrimmedBall CorporationMarch 2026
“As the thesis played out, we sold into the re-rating and redeployed proceeds into more attractive opportunities.”
Read the letter - ExitedKennedy WilsonMarch 2026
“In addition to Ball, noted previously, we liquidated profitable investments in Kenedy Wilson and Fresenius Medical Care,”
Read the letter - TrimmedAvantorDecember 2025
“Consequently, we cut the position in half after the company announced management changes and second-quarter results that again fell short of our expectations, and reinvested the proceeds into Thermo Fisher, the primary beneficiary of Avantor’s challenges.”
Read the letter - December 2025
“as our conviction in the opportunity deepened, we increased our exposure through a dedicated investment vehicle alongside a small group of partners.”
Read the letter - New positionThermo Fisher ScientificDecember 2025
“Consequently, we cut the position in half after the company announced management changes and second-quarter results that again fell short of our expectations, and reinvested the proceeds into Thermo Fisher, the primary beneficiary of Avantor’s challenges.”
Read the letter
Companies held · 26
Every company Broyhill has disclosed a position in across our archive, with the letter that last mentioned it.
- Alphabet Inc.Sep 2026
- AvantorDec 2025
- Ball CorporationMar 2026
- CACI International Inc.Sep 2026
- Dollar TreeJul 2026
- EvolutionMar 2026
- Floor and DécorMar 2026
- Fresenius Medical CareMar 2026
- Honeywell International Inc.Sep 2026
- IQVIA Holdings Inc.Sep 2026
- Kennedy WilsonMar 2026
- Louis VuittonMar 2026
- LVMHMay 2026
- Masco CorporationSep 2026
- Microsoft CorporationSep 2026
- Middleby CorporationSep 2026
- Midera Food ProcessingSep 2026
- NestléJul 2026
- Philip Morris InternationalMay 2026
- Reckitt BenckiserDec 2025
- Rentokil Initial plcSep 2026
- Smurfit WestRockJul 2026
- Sotera HealthMay 2026
- Thermo Fisher Scientific Inc.Sep 2026
- Valvoline Inc.Sep 2026
- Watches of SwitzerlandDec 2025
Theses · 12
- September 2026
Thermo Fisher Scientific is benefiting from broad-based demand recovery and management’s raised guidance.
Read the full thesis - September 2026
Microsoft is seeing accelerating Azure growth, widening Copilot adoption, and strong free cash flow despite AI capex concerns.
Read the full thesis - September 2026
Valvoline is supported by execution, pricing power, and a view that pricing can persist even if base oil costs normalize.
Read the full thesis - September 2026
Alphabet was bought after a sell-off because demand exceeds supply and its TPU exposure offers attractive AI-related optionality.
Read the full thesis - September 2026
Honeywell Aerospace is attractive for its entrenched supply-chain position, high ROIC, and strong free cash flow.
Read the full thesis - May 2026
Masco is attractive for its repair-and-remodel exposure, pricing power, growth targets, and shareholder returns.
Read the full thesis - March 2026
IQVIA is a clinical research organization with sticky pharma demand, proprietary data, and valuation support despite AI concerns.
Read the full thesis - March 2026
Sotera Health is a mission-critical sterilization business with a duopoly position and valuation support despite litigation overhangs.
Read the full thesis - March 2026
Masco is a housing-related company whose normalized earnings power has improved through market share gains and expense efficiencies.
Read the full thesis - December 2025
Reckitt Benckiser is a focused hygiene and health company trading at a discount with multiple catalysts and defensiveness.
Read the full thesis - December 2025
Watches of Switzerland is a leading Rolex retailer with a high-margin model and attractive valuation.
Read the full thesis - December 2025
Avantor is a strategic life-sciences supplier with self-help levers amid an industry upturn despite execution issues.
Read the full thesis
Letter archive · 6
2026
Get Broyhill’s next letter the day it lands
We track Broyhill alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.
View plans→